HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NAD reviews hair-loss product

This article was originally published in The Rose Sheet

Executive Summary

Lifes2Good Natural Healthcare has been advised to modify advertising for its Viviscal dietary supplement - which nourishes the hair follicle with vitamin C, silica and glycosaminoglycans - to assure it is gender-neutral, according to the National Advertising Division. The ads in question included radio, print and Internet ads, including one that featured the testimonial of an actress and "health enthusiast" along with the statement that one in three women will be affected by thinning hair during their lifetime. The Council of Better Business Bureaus division determined that because the studies supporting the efficacy of the product were only conducted on men, the advertiser should revise ads to avoid indicating that the product has been shown to work in women. NAD also recommended the firm discontinue claims asserting that the product is "doctor recommended." Lifes2Good was able to substantiate one claim: "Recommended by top celebrities and models." Though Lifes2Good says it disagrees with NAD's decision regarding the gender focus of its ads, it will comply with the watchdog's recommendation

Lifes2Good Natural Healthcare has been advised to modify advertising for its Viviscal dietary supplement - which nourishes the hair follicle with vitamin C, silica and glycosaminoglycans - to assure it is gender-neutral, according to the National Advertising Division. The ads in question included radio, print and Internet ads, including one that featured the testimonial of an actress and "health enthusiast" along with the statement that one in three women will be affected by thinning hair during their lifetime. The Council of Better Business Bureaus division determined that because the studies supporting the efficacy of the product were only conducted on men, the advertiser should revise ads to avoid indicating that the product has been shown to work in women. NAD also recommended the firm discontinue claims asserting that the product is "doctor recommended." Lifes2Good was able to substantiate one claim: "Recommended by top celebrities and models." Though Lifes2Good says it disagrees with NAD's decision regarding the gender focus of its ads, it will comply with the watchdog's recommendations

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016721

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel